Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

VR headsets tested as Drug-Free pain relief for End-of-Life care

NCT ID NCT07214090

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a virtual reality headset for 10 minutes a day can reduce pain, anxiety, and fatigue in people receiving palliative care. Forty adults with complex needs will be randomly assigned to either a fully immersive VR experience or a control version that keeps them aware of their real surroundings. Researchers will measure changes in pain scores and physiological signals like heart rate and brain activity over one week.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality (VR) headset
What this could lead to
If it works, this could offer a drug-free way to ease pain and anxiety for people in palliative care, improving their comfort and quality of life.
What could go wrong
This is a very small pilot study with only 40 people, so results may not apply to everyone. The effect may be small or no better than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study participants will be recruited from the palliative care unit or through the mobile palliative care team at Strasbourg University Hospitals.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient ≥ 18 years old * Hospitalized in the palliative care unit or followed by the mobile palliative care team of the Strasbourg University Hospitals * Estimated life expectancy \> 1 month (Pronopall score calculated based on medical record data) * Affiliated with a social security scheme * Able to understand the objectives and risks of the trial * Able to understand and complete study questionnaires written in French * Reachable by phone or email for the entire duration of participation in the study Exclusion Criteria: * Patient with a psychotic mental illness, followed and treated before the study, and not stabilized * Patient with a severe neurological disease, followed and treated before the study, and not stabilized * Patient with visual or auditory disorders, or motion sickness, present before the study, that could interfere with the use of virtual reality * Patient under legal protection or unable to express their consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Palliative care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.